IMMUTEP ANNOUNCES AUSTRALIAN PATENT GRANT FOR IMP701 ANTIBODY
Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) announces 2015229103 entitled “Antibody molecules to LAG- 3 and uses thereof” by the Australian Patent Office.
Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”) announces 2015229103 entitled “Antibody molecules to LAG- 3 and uses thereof” by the Australian Patent Office.
Eternygen announces today the first closing of its Series A2 funding round led by new anchor investor Evotec SE and additional funding from venture capital firms Epidarex Capital, IBB Ventures and a number of family offices. The new investment…
The “Mobile Autonomy for Children in End-stage Heart Failure” (MACH) project wins the 2020 Horizon Impact Award. This project was an international collaboration between RWTH Aachen University, Uniklinik RWTH Aachen, Newcastle upon Tyne Hospitals NHS…
Double interview with Prof. Dr. Christian Drosten, Director of the Institute of Virology at Charité Berlin and speaker at the World Health Summit, and Prof. Dr. Detlev Ganten, President and Founder of the World Health Summit.
Aignostics, a spin-off from Charité – Universitätsmedizin Berlin and the Berlin Institute of Health, pioneering computational pathology for pharmaceutical research and diagnostics, has announced today the closing of €5m in seed round funding.…
CARE (Corona Accelerated R&D in Europe), supported by Europe’s Innovative Medicines Initiative (IMI), is the largest undertaking of its kind dedicated to discovering and developing urgently needed treatment options for COVID-19.
The initiative is…
Myelo Therapeutics GmbH, a clinical-stage pharmaceutical company focused on developing therapies for cancer supportive care and medical countermeasures (MCM), announced today the successful closing of a multi-million Euro financing round, following…
The history of the pharmaceutical company Takeda from Japan has been 239 years, for 39 years
Takeda is active in Germany. During this time it has acquired and developed the current locations in Berlin, Oranienburg, Konstanz and Singen. In…
The development of drugs for the treatment of rare diseases is difficult, as is the development of safe methods of diagnosis. Although the number of patients suffering from rare diseases is relatively large, the estimated 8,000 different rare…
In late January the Sars-Cov-2 pandemic officially arrived and started spreading across Germany. Since then – like in almost every other country globally - every new day feels completely new, uncertain and presents previously unknown challenges,…